Immunogenicity of a subunit vaccine against Bacillus anthracis
April 20, 2007
The current approved vaccine against anthrax is based on protective antigen (PA) of Bacillus anthracis, requires six injections over an 18-month period and has a known history of side effects. Therefore, there is significant effort towards developing an …